Cargando…

Pharmacists’ chronic disease management in chronic obstructive pulmonary disease: Effect on health services utilization

BACKGROUND: There is limited real-world evidence on evaluation of chronic disease management initiatives provided by pharmacists to patients with chronic obstructive pulmonary disease (COPD). OBJECTIVE: To evaluate changes in COPD-related health care resource utilization between patients with COPD w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makhinova, Tatiana, Johnson, Jeffrey A, Minhas-Sandhu, Jasjeet K, Necyk, Candace, Bhutani, Mohit, Eurich, Dean T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388007/ https://www.ncbi.nlm.nih.gov/pubmed/37276041 http://dx.doi.org/10.18553/jmcp.2023.29.6.671

Ejemplares similares

Exploring the impact of pharmacist comprehensive annual care plans on perceived quality of chronic illness care by patients in Alberta, Canada
por: Necyk, Candace, et al.
Publicado: (2021)

Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up
por: Eurich, Dean T, et al.
Publicado: (2017)

Temporal Trends Of Pharmacologic Therapies For Patients With Chronic Obstructive Pulmonary Disease In Alberta, Canada
por: Tran, Dat T, et al.
Publicado: (2019)

Effectiveness of RADAR: An Innovative Model to Organize Diabetes Care in First Nations Communities
por: Eurich, Dean T., et al.
Publicado: (2023)

Community Pharmacists’ Views and Practices Regarding Natural Health Products Sold in Community Pharmacies
por: Ogbogu, Ubaka, et al.
Publicado: (2016)

A Patient Charter for Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2020)

Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014–2017 in Ontario, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study
por: Alkabbani, Wajd, et al.
Publicado: (2021)

Five comparative cohorts to assess the risk of genital tract infections associated with sodium‐glucose cotransporter‐2 inhibitors initiation in type 2 diabetes mellitus
por: Alkabbani, Wajd, et al.
Publicado: (2022)

Dataset on cost-analysis of medication deprescribing scenarios for older adult coverage under public drug benefit programs in Canada
por: Fadaleh, Sarah Abu, et al.
Publicado: (2020)

Emerging role of pharmacists in managing patients with chronic obstructive pulmonary disease
por: Hudd, Timothy R
Publicado: (2020)

Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management
por: Li, Liu-Cheng, et al.
Publicado: (2021)

Effect of a pharmacy comprehensive chronic diseases care plan on use of lipid-lowering drugs among patients with hypertension
por: Zongo, Arsène, et al.
Publicado: (2021)

Chronic disease surveillance in Alberta’s tomorrow project using administrative health data
por: Ye, Ming, et al.
Publicado: (2021)

Experience of Patients with COPD of Pharmacists’ Provided Care: A Qualitative Study
por: Idowu, Omowumi, et al.
Publicado: (2021)

Knowledge, Attitude and Practice of Lebanese Community Pharmacists toward Chronic Obstructive Pulmonary Disease
por: Hallit, Souheil, et al.
Publicado: (2020)

Fractional Exhaled Nitric Oxide Testing: Diagnostic Utility in Asthma, Chronic Obstructive Pulmonary Disease, or Asthma-chronic Obstructive Pulmonary Disease Overlap Syndrome
por: Miskoff, Jeffrey A, et al.
Publicado: (2019)

Anti-Hyperglycemic Medication Adherence and Health Services Utilization in People with Diabetes: A Longitudinal Study of Alberta’s Tomorrow Project
por: Ye, Ming, et al.
Publicado: (2022)

Improving Asthma Management: Patient–Pharmacist Partnership Program in Enhancing Therapy Adherence
por: Makhinova, Tatiana, et al.
Publicado: (2022)

The Role of the Clinical Pharmacist on the Health Outcomes of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)
por: Gong, Yanqing, et al.
Publicado: (2022)

Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic
por: Dwyer, Gregory, et al.
Publicado: (2022)

Effectiveness of a standardized electronic admission order set for acute exacerbation of chronic obstructive pulmonary disease
por: Pendharkar, Sachin R., et al.
Publicado: (2018)

The impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary disease
por: Roberts, Melissa H, et al.
Publicado: (2015)

Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India
por: Abdulsalim, Suhaj, et al.
Publicado: (2019)

Examining changes in vascular function, arterial stiffness and systemic inflammation during hospitalization and recovery from an acute exacerbation of chronic obstructive pulmonary disease
por: Fuhr, Desi P., et al.
Publicado: (2023)

Australian Community Pharmacists’ Experience of Implementing a Chronic Kidney Disease Risk Assessment Service
por: Gheewala, Pankti A., et al.
Publicado: (2018)

A comment on the drug utilization pattern in chronic obstructive pulmonary disease
por: Chauhan, Renu
Publicado: (2015)

Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2015)

Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs
por: Luyster, Faith S., et al.
Publicado: (2023)

Factors influencing the implementation and uptake of a discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease: a qualitative focus group study
por: Michas, Marta, et al.
Publicado: (2020)

Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease
por: Hasegawa, Kohei, et al.
Publicado: (2014)

Author reply: comment on the drug utilization pattern in chronic obstructive pulmonary disease
por: Veettil, Sajesh Kalkandi, et al.
Publicado: (2015)

Challenges in the management of chronic noncommunicable diseases by Indonesian community pharmacists
por: Puspitasari, Hanni P., et al.
Publicado: (2015)

Pharmacists' Role in Chronic Disease Management from Physicians' Perspective
por: Shah, Arsalan, et al.
Publicado: (2019)

Role of Pharmacists in the Interprofessional Care Team for Patients with Chronic Diseases
por: Rahayu, Susi Afrianti, et al.
Publicado: (2021)

Consequences of chronic kidney disease in chronic obstructive pulmonary disease
por: Trudzinski, Franziska C., et al.
Publicado: (2019)

Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England
por: Sansbury, Leah B, et al.
Publicado: (2022)

Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, Canada
por: Houle, Sherilyn K. D., et al.
Publicado: (2019)

Chronic obstructive pulmonary disease
por: Vijayan, V.K.
Publicado: (2013)

Chronic obstructive pulmonary disease
por: Madison, J Mark, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_ff1jbd2b33m9g7n1hbcoi9hc64